HK1022301A1 - Conjugates of cisdocosahexaenoic acid and paclitaxel - Google Patents
Conjugates of cisdocosahexaenoic acid and paclitaxelInfo
- Publication number
- HK1022301A1 HK1022301A1 HK99105092A HK99105092A HK1022301A1 HK 1022301 A1 HK1022301 A1 HK 1022301A1 HK 99105092 A HK99105092 A HK 99105092A HK 99105092 A HK99105092 A HK 99105092A HK 1022301 A1 HK1022301 A1 HK 1022301A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- conjugates
- paclitaxel
- acid
- cisdocosahexaenoic
- cis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/653,951 US5919815A (en) | 1996-05-22 | 1996-05-22 | Taxane compounds and compositions |
PCT/US1997/008792 WO1997044336A1 (en) | 1996-05-22 | 1997-05-22 | Conjugates of cis-docosahexaenoic acid and paclitaxel |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1022301A1 true HK1022301A1 (en) | 2000-08-04 |
Family
ID=24622927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK99105092A HK1022301A1 (en) | 1996-05-22 | 1999-11-05 | Conjugates of cisdocosahexaenoic acid and paclitaxel |
Country Status (11)
Country | Link |
---|---|
US (1) | US5919815A (xx) |
EP (1) | EP0912535B1 (xx) |
JP (1) | JP4172725B2 (xx) |
AT (1) | ATE208382T1 (xx) |
AU (1) | AU720704B2 (xx) |
CA (1) | CA2255637C (xx) |
DE (1) | DE69708100T2 (xx) |
DK (1) | DK0912535T3 (xx) |
ES (1) | ES2162681T3 (xx) |
HK (1) | HK1022301A1 (xx) |
WO (1) | WO1997044336A1 (xx) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
US5795909A (en) * | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
EP0870510A3 (en) * | 1997-04-11 | 1999-09-15 | Eli Lilly And Company | Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents |
AU756752B2 (en) * | 1998-04-01 | 2003-01-23 | Skyepharma Canada Inc. | Anticancer compositions |
DE19842415A1 (de) * | 1998-09-16 | 2000-03-23 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
DE69926535T2 (de) * | 1998-12-18 | 2006-03-30 | Scios Inc., Sunnyvale | Behandlung von erkrankungen mit zystenbildung |
US7235583B1 (en) | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
WO2000053231A2 (en) * | 1999-03-09 | 2000-09-14 | Protarga, Inc. | Fatty acid-anticancer conjugates and uses thereof |
US7303749B1 (en) * | 1999-10-01 | 2007-12-04 | Immunogen Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
JP4776843B2 (ja) | 1999-10-01 | 2011-09-21 | イムノゲン インコーポレーティッド | 免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法 |
US6890946B2 (en) * | 1999-12-23 | 2005-05-10 | Indiana University Research And Technology Corporation | Use of parthenolide to inhibit cancer |
US6660750B2 (en) | 2000-02-15 | 2003-12-09 | University Of Iowa Research Foundation | Flavopiridol methods and compositions for HIV therapy |
CA2397425A1 (en) * | 2000-02-29 | 2001-09-07 | Ivan David Horak | Farnesyl protein transferase inhibitor combinations with taxane compounds |
DE10012120A1 (de) * | 2000-03-13 | 2001-09-27 | Ktb Tumorforschungs Gmbh | Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel |
US7097840B2 (en) * | 2000-03-16 | 2006-08-29 | Genentech, Inc. | Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
WO2001072299A1 (en) * | 2000-03-24 | 2001-10-04 | Baker Norton Pharmaceuticals, Inc. | Taxane-based compositions and methods of use |
GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
DE60131537T2 (de) | 2000-06-22 | 2008-10-23 | Nitromed, Inc., Lexington | Nitrosierte und nitrosylierte taxane, zubereitungen und methoden der verwendung |
AU2002222931A1 (en) | 2000-07-19 | 2002-01-30 | University Of Pittsburgh | Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a |
AU2001281250A1 (en) | 2000-08-11 | 2002-02-25 | The Brigham And Women's Hospital, Inc. | (hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production |
US20040253891A1 (en) * | 2000-09-12 | 2004-12-16 | Schierenbeck Alan W. | Composite structure for protective garment |
US20040091509A1 (en) * | 2000-12-14 | 2004-05-13 | Avon Products, Inc. | Skin care composition that mediates cell to cell communication |
US7037906B1 (en) * | 2000-12-22 | 2006-05-02 | Oxigene, Inc. | Methods for modulating tumor growth and metastasis |
US20050209310A1 (en) * | 2000-12-22 | 2005-09-22 | Chaplin David J | Methods for modulating tumor growth and metastasis |
AU2002303164A1 (en) * | 2001-03-23 | 2002-10-08 | Protarga, Inc. | Fatty amine drug conjugates |
AU2002305099A1 (en) | 2001-03-23 | 2002-10-08 | Protarga, Inc. | Fatty alcohol drug conjugates |
MY140679A (en) * | 2001-05-24 | 2010-01-15 | Avanir Pharmaceuticals | Inhibitors of macrohage migration inhibitory factor and methods for identifying the same |
WO2002097038A2 (en) * | 2001-05-25 | 2002-12-05 | Human Genome Sciences, Inc. | Chemokine beta-1 fusion proteins |
DE10142881A1 (de) * | 2001-09-03 | 2003-04-03 | Jomed Gmbh | Implantate mit Combretastatin A-4 (CA4) |
WO2003045334A2 (en) * | 2001-11-29 | 2003-06-05 | Sound Pharmaceuticals Incorporated | Methods and compositions for ameliorating the undesirable effects of chemotherapy |
ES2500918T3 (es) | 2001-12-21 | 2014-10-01 | Human Genome Sciences, Inc. | Proteínas de fusión de albúmina e interferón beta |
JP2006501205A (ja) * | 2002-07-30 | 2006-01-12 | カリキオン インコーポレイテッド | エゼチミブ組成物、並びにコレステロールに関連した良性および悪性の腫瘍を治療する方法 |
US7119200B2 (en) | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
AR041133A1 (es) * | 2002-09-04 | 2005-05-04 | Pharmacopeia Drug Discovery | Pirazolopirimidinas como inhibidores de la quinasa dependientes de la ciclina |
CN1694705A (zh) * | 2002-09-04 | 2005-11-09 | 先灵公司 | 用作依赖细胞周期蛋白激酶抑制剂的吡唑并嘧啶 |
US7205308B2 (en) * | 2002-09-04 | 2007-04-17 | Schering Corporation | Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
MY141978A (en) * | 2002-09-04 | 2010-08-16 | Schering Corp | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7161003B1 (en) | 2002-09-04 | 2007-01-09 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7078525B2 (en) | 2002-09-04 | 2006-07-18 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7196078B2 (en) * | 2002-09-04 | 2007-03-27 | Schering Corpoartion | Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
CA2504933C (en) * | 2002-11-06 | 2012-10-16 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for treating cancer using proteasome inhibitors |
TW200418829A (en) * | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US20070190191A1 (en) * | 2003-04-15 | 2007-08-16 | Francis Raul | Use of geraniol in antitumoral therapy |
US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
US8092787B2 (en) * | 2003-05-22 | 2012-01-10 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced effect of optical modifier separate from structured benefit agent |
US20050101623A1 (en) * | 2003-07-23 | 2005-05-12 | Pharmacia Corporation | Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
US20050107350A1 (en) * | 2003-08-22 | 2005-05-19 | Pharmacia Corporation | Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith |
US20050187278A1 (en) * | 2003-08-28 | 2005-08-25 | Pharmacia Corporation | Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors |
US6949895B2 (en) * | 2003-09-03 | 2005-09-27 | Axcelis Technologies, Inc. | Unipolar electrostatic quadrupole lens and switching methods for charged beam transport |
US20050148534A1 (en) * | 2003-09-22 | 2005-07-07 | Castellino Angelo J. | Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
JP2007509978A (ja) | 2003-10-29 | 2007-04-19 | ソーナス ファーマシューティカルズ, インコーポレイテッド | トコフェロール修飾治療薬化合物 |
CA2544128A1 (en) * | 2003-10-30 | 2005-05-12 | The Research Foundation Of State University Of New York | Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
US20070117861A1 (en) * | 2003-11-12 | 2007-05-24 | University Of South Carolina | Treatment or prevention of cardiovascular and respiratory disorders with novel substituted cyclic-amp specific phosphodiesterase inhibitors |
WO2005118634A2 (en) * | 2004-06-04 | 2005-12-15 | The Brigham And Women's Hospital, Inc. | Helical peptidomimetics with enhanced activity against beta-amyloid production |
US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
US8080560B2 (en) * | 2004-12-17 | 2011-12-20 | 3M Innovative Properties Company | Immune response modifier formulations containing oleic acid and methods |
AU2006220626A1 (en) * | 2005-03-08 | 2006-09-14 | Sound Pharmaceuticals Incorporated | Methods and compositions for treating cancer |
BRPI0609382A2 (pt) * | 2005-03-24 | 2010-03-30 | Avanir Pharmaceuticals | derivados da tienopiridinona como inibidores do fator inibitório de migração de macrófagos |
CA2607940C (en) | 2005-05-18 | 2009-12-15 | Aegera Therapeutics Inc. | Bir domain binding compounds |
JP2008523111A (ja) * | 2005-10-12 | 2008-07-03 | シコール インコーポレイティド | ドセタキセルの結晶形及びそれらの調製方法 |
TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
GB0605689D0 (en) * | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
KR101506466B1 (ko) | 2006-05-16 | 2015-03-27 | 파마사이언스 인크. | Iap bir 도메인 결합 화합물 |
FR2902659A1 (fr) * | 2006-06-23 | 2007-12-28 | Pierre Fabre Medicament Sa | Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires |
US20080051380A1 (en) | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods and compositions for treating cancer |
US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
EP2152312B1 (en) * | 2007-05-16 | 2014-12-31 | KTB Tumorforschungsgesellschaft mbH | Low-viscous anthracycline formulation |
WO2008151253A1 (en) * | 2007-06-04 | 2008-12-11 | Threshold Pharmaceuticals, Inc. | Hypoxia activated prodrugs of antineoplastic agents |
US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
JP2010533714A (ja) * | 2007-07-16 | 2010-10-28 | ポニアード ファーマシューティカルズ, インコーポレイテッド | ピコプラチンのための経口製剤 |
UA99836C2 (xx) * | 2007-09-26 | 2012-10-10 | Маунт Синай Скул Оф Медсин | Аналоги азацитидину та їх застосування$аналоги азацитидина и их применение |
CN102014624A (zh) * | 2008-02-08 | 2011-04-13 | 帕纳德制药公司 | 治疗肺癌的吡铂和氨柔比星 |
MY188477A (en) | 2008-03-18 | 2021-12-13 | Genentech Inc | Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
CN102439071A (zh) * | 2009-03-12 | 2012-05-02 | 路脱坡德药品股份有限公司 | Gaba连接的蒽环-脂质缀合物 |
KR20120140658A (ko) | 2010-02-12 | 2012-12-31 | 파마사이언스 인크. | Iap bir 도메인 결합 화합물 |
PL226015B1 (pl) | 2011-03-03 | 2017-06-30 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną | Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna |
CA2944401A1 (en) | 2014-04-03 | 2015-10-08 | Invictus Oncology Pvt. Ltd. | Supramolecular combinatorial therapeutics |
CA3031705A1 (en) | 2016-07-29 | 2018-02-01 | Janssen Pharmaceutica Nv | Treatment of prostate cancer with niraparib |
EP3752130A4 (en) * | 2017-12-20 | 2022-12-21 | Targagenix, Inc. | COMBINATION OF TAXOID NANOEMULSION AND IMMUNOTHERAPY IN CANCER |
WO2024110843A1 (en) | 2022-11-21 | 2024-05-30 | Segena Corporation S.A. | Enhancing oligonucleotide immunomodulatory activity through dianophore long-lasting modification: methods and applications |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4351831A (en) * | 1977-11-02 | 1982-09-28 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering isoxsurpine and choline |
IT7927748A0 (it) * | 1979-11-30 | 1979-11-30 | Simes | Derivati dell'acido 6,6'-diapopsi psicarotenedioico e relativi procedimenti di preparazione. |
US4346085A (en) * | 1980-02-29 | 1982-08-24 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering amphetamine and choline |
US4636494A (en) * | 1981-01-30 | 1987-01-13 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering amphetamine and choline |
JPS58177953A (ja) * | 1982-04-13 | 1983-10-18 | Eisai Co Ltd | ポリプレニルカルボン酸アミドおよびその製造方法 |
JPS5925327A (ja) * | 1982-07-31 | 1984-02-09 | Hidematsu Hirai | 抗腫瘍性複合体の製造方法 |
WO1985000520A1 (en) * | 1983-08-01 | 1985-02-14 | The Mclean Hospital Corporation | Gaba esters and gaba analogue esters |
US4550109A (en) * | 1984-05-31 | 1985-10-29 | The Board Of Regents, The University Of Texas System | Lipoidal biopterin compounds |
US4684646A (en) * | 1984-06-26 | 1987-08-04 | Merck & Co., Inc. | 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists |
US4554272A (en) * | 1985-01-25 | 1985-11-19 | Merck & Co., Inc. | Substituted quinazolino-1,4-benzodiazepin-6,9-diones and their preparation |
US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
US5246726A (en) * | 1986-03-21 | 1993-09-21 | Efamol Ltd. | Iron-containing composition and method for treatment of cancer |
FR2601676B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Procede de preparation du taxol et du desacetyl-10 taxol |
FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
US4968672A (en) * | 1987-01-02 | 1990-11-06 | The United States Of America As Represented By The Department Of Health And Human Services | Adenosine receptor prodrugs |
JPH01153629A (ja) * | 1987-12-11 | 1989-06-15 | Nippon Oil & Fats Co Ltd | 制癌剤 |
JPH01203331A (ja) * | 1988-02-05 | 1989-08-16 | Rikagaku Kenkyusho | 制癌剤 |
US4933324A (en) * | 1988-02-26 | 1990-06-12 | Shashoua Victor E | Fatty acid-neuroactive drug conjugate as a prodrug |
US4939174A (en) * | 1988-02-26 | 1990-07-03 | Shashoua Victor E | Appetite suppression with dopamine-fatty acid conjugates |
US4942184A (en) * | 1988-03-07 | 1990-07-17 | The United States Of America As Represented By The Department Of Health And Human Services | Water soluble, antineoplastic derivatives of taxol |
JPH01287022A (ja) * | 1988-05-12 | 1989-11-17 | Nippon Oil & Fats Co Ltd | 抗癌剤耐性克服剤 |
GB8813766D0 (en) * | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
CH676909A5 (xx) * | 1988-12-23 | 1991-03-28 | Nestle Sa | |
HU207287B (en) * | 1989-01-17 | 1993-03-29 | Biosignal Kutato Fejlesztoe Kf | Polyene fatty acid derivatives of tyrozine-quinaze inhibiting activity and pharmaceutical composition containing them as active component |
US4960790A (en) * | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
GB8918294D0 (en) * | 1989-08-10 | 1989-09-20 | Efamol Holdings | Pharmaceutical compositions |
GB9001121D0 (en) * | 1990-01-18 | 1990-03-21 | Efamol Holdings | Efa compositions and therapy |
MX9102128A (es) * | 1990-11-23 | 1992-07-08 | Rhone Poulenc Rorer Sa | Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene |
IT1254517B (it) * | 1992-03-06 | 1995-09-25 | Indena Spa | 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico |
IT1254515B (it) * | 1992-03-06 | 1995-09-25 | Indena Spa | Tassani di interesse oncologico, loro metodo di preparazione ed uso |
GB9213077D0 (en) * | 1992-06-19 | 1992-08-05 | Erba Carlo Spa | Polymerbound taxol derivatives |
JPH0616548A (ja) * | 1992-06-30 | 1994-01-25 | Sagami Chem Res Center | 組織異常増殖抑制剤 |
FR2696461B1 (fr) * | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent. |
US5453521A (en) * | 1992-10-05 | 1995-09-26 | Rhone-Poulenc Rorer S.A. | Process for obtaining 10-deacetylbaccatin III |
US5356928A (en) * | 1992-11-06 | 1994-10-18 | Hauser Chemical Research, Inc. | Cytotoxic agents |
FR2697841B1 (fr) * | 1992-11-12 | 1995-01-13 | Rhone Poulenc Rorer Sa | Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent. |
GB9224809D0 (en) * | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
CA2150470A1 (en) * | 1992-11-30 | 1994-06-09 | S.P.I. Synthetic Peptides Incorporated | Polyunsaturated fatty acyl-peptide composition |
FR2698871B1 (fr) * | 1992-12-09 | 1995-02-24 | Rhone Poulenc Rorer Sa | Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
US5643909A (en) * | 1993-04-19 | 1997-07-01 | Syntex (U.S.A.) Inc. | 10,11-Methanodibenzosuberane derivatives |
US5336684A (en) * | 1993-04-26 | 1994-08-09 | Hauser Chemical Research, Inc. | Oxidation products of cephalomannine |
FR2707293A1 (fr) * | 1993-07-08 | 1995-01-13 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent. |
FR2712288B1 (fr) * | 1993-11-08 | 1996-01-05 | Rhone Poulenc Rorer Sa | Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
FR2712289B1 (fr) * | 1993-11-08 | 1996-01-05 | Rhone Poulenc Rorer Sa | Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent. |
US5447936A (en) * | 1993-12-22 | 1995-09-05 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof |
US5468754A (en) * | 1994-04-19 | 1995-11-21 | Bionumerik Pharmaceuticals, Inc. | 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof |
FR2721023B1 (fr) * | 1994-06-09 | 1996-07-12 | Rhone Poulenc Rorer Sa | Nouveaux Taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
FR2721928A1 (fr) * | 1994-07-04 | 1996-01-05 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
JPH0827010A (ja) * | 1994-07-19 | 1996-01-30 | Nichinichi Seiyaku Kk | 制癌免疫療法剤 |
EP0952841A4 (en) * | 1994-08-05 | 2000-11-02 | Molecular Structural Biotechno | DIRECTED BIOMOLECULAR COMPLEXES |
JPH08163991A (ja) * | 1994-12-15 | 1996-06-25 | Mitsui Petrochem Ind Ltd | タキサン型ジテルペンの製造方法 |
US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
GB9508823D0 (en) * | 1995-05-01 | 1995-06-21 | Scotia Holdings Plc | Drug Derivatives |
JPH0925231A (ja) * | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | 癌転移抑制剤 |
-
1996
- 1996-05-22 US US08/653,951 patent/US5919815A/en not_active Expired - Lifetime
-
1997
- 1997-05-22 DE DE69708100T patent/DE69708100T2/de not_active Expired - Lifetime
- 1997-05-22 EP EP97930990A patent/EP0912535B1/en not_active Expired - Lifetime
- 1997-05-22 CA CA002255637A patent/CA2255637C/en not_active Expired - Fee Related
- 1997-05-22 ES ES97930990T patent/ES2162681T3/es not_active Expired - Lifetime
- 1997-05-22 DK DK97930990T patent/DK0912535T3/da active
- 1997-05-22 JP JP54278097A patent/JP4172725B2/ja not_active Expired - Fee Related
- 1997-05-22 AT AT97930990T patent/ATE208382T1/de not_active IP Right Cessation
- 1997-05-22 WO PCT/US1997/008792 patent/WO1997044336A1/en active IP Right Grant
- 1997-05-22 AU AU34734/97A patent/AU720704B2/en not_active Ceased
-
1999
- 1999-11-05 HK HK99105092A patent/HK1022301A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE208382T1 (de) | 2001-11-15 |
ES2162681T3 (es) | 2002-01-01 |
JP2000511187A (ja) | 2000-08-29 |
AU3473497A (en) | 1997-12-09 |
US5919815A (en) | 1999-07-06 |
EP0912535B1 (en) | 2001-11-07 |
CA2255637A1 (en) | 1997-11-27 |
CA2255637C (en) | 2005-01-04 |
DE69708100T2 (de) | 2002-04-11 |
DE69708100D1 (de) | 2001-12-13 |
WO1997044336A1 (en) | 1997-11-27 |
AU720704B2 (en) | 2000-06-08 |
EP0912535A1 (en) | 1999-05-06 |
DK0912535T3 (da) | 2002-02-25 |
JP4172725B2 (ja) | 2008-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1022301A1 (en) | Conjugates of cisdocosahexaenoic acid and paclitaxel | |
DK0914116T3 (da) | Kompositstoffer omfattende konjugater af cis-docosahexaensyre og Taxotere | |
DE69716135D1 (en) | In 6-position durch thio substituierte paclitaxele | |
IL189132A0 (en) | Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer | |
EP0926955A4 (en) | Conjugates useful in the treatment of prostate cancer | |
YU15299A (sh) | Farmaceutski sastavi | |
CA2301032A1 (en) | A method of preventing or treating estrogen-dependent diseases and disorders | |
PT1187632E (pt) | Tratamento com anticorpos anti-erbb2 | |
DE59611481D1 (en) | Chromatin-regulatorgene | |
IL129356A0 (en) | Conjugates useful in the treatment of prostate cancer | |
BG103832A (en) | Leptin as tumour cells proliferation inhibitor | |
IL136167A0 (en) | Conjugates useful in the treatment of prostate cancer | |
WO2000053231A3 (en) | Fatty acid-anticancer conjugates and uses thereof | |
ES2151508T3 (es) | Empleo de inhibidores de reductasa 3-hidroxi-3-metilglutaril coenzima a como una modalidad en la terapia del cancer. | |
NO994631D0 (no) | Fremgangsmaater og sammensetninger for behandling av eggstokkreft | |
HK1043058A1 (zh) | 異環磷酰胺芥子類似物及其用途 | |
DE69835828D1 (de) | Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression | |
ZA9810974B (en) | Conjugates useful in the treatment of prostate cancer | |
DE69818492D1 (en) | 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele | |
ZA979655B (en) | Conjugates useful in the treatment of prostate cancer. | |
HK1034979A1 (en) | Conjugates useful in the treatment of prostate cancer. | |
GB9626309D0 (en) | Conjugates useful in the treatment of prostate cancer | |
GB9624170D0 (en) | Conjugates useful in the treatment of prostate cancer | |
GB9718160D0 (en) | Conjugates useful in the treatment of prostate cancer | |
ZA988293B (en) | Compositions and methods for the treatment of tumor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
AS | Change of ownership |
Owner name: LUITPOLD PHARMACEUTICALS, INC. Free format text: FORMER OWNER(S): PROTARGA INC |
|
CHPA | Change of a particular in the register (except of change of ownership) | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130522 |